1. Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy;Glueck;Eur. J. Obstet. Gynecol. Reprod. Biol.,2005
2. At the crossroads of fertility and metabolism: the importance of AMPK-dependent signaling in female infertility associated with hyperandrogenism;Froment;Hum. Reprod.,2022
3. Polycystic ovary syndrome, obesity and reproductive implications;Hirschberg;WOMENS HEALTH,2009
4. Genetic basis of polycystic ovary syndrome (PCOS): current perspectives;Khan;Appl. Clin. Genet.,2019
5. Controversies in the pathogenesis, diagnosis and treatment of PCOS: focus on insulin resistance, inflammation, and hyperandrogenism;Armanini;Int. J. Mol. Sci.,2022